Exosomes research in pathophysiology of peritoneal metastatic gastric cancer

doi:10.16139/j.1007-9610.2021.01.016

Abstract

CLC Number:

R735.2

LIU Xuanyu, CHEN Lei. Exosomes research in pathophysiology of peritoneal metastatic gastric cancer[J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 76-78.

References 29

[1]	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-E386.
[2]	Wang Z, Chen JQ, Liu JL, et al. Issues on peritoneal metastasis of gastric cancer: an update[J]. World J Surg Oncol, 2019, 17(1):215.
[3]	Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer[J]. World J Gastroenterol, 2016, 22(30):6829-6840.
[4]	Isola AL, Chen S. Exosomes: the messengers of health and disease[J]. Curr Neuropharmacol, 2017, 15(1):157-165.
[5]	van Dommelen SM, Vader P, Lakhal S, et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery[J]. J Control Release, 2012, 161(2):635-644.
[6]	Han L, Lam EW, Sun Y. Extracellular vesicles in the tumor microenvironment: old stories, but new tales[J]. Mol Cancer, 2019, 18(1):59.
[7]	Yashiro M, Chung YS, Nishimura S, et al. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination[J]. Cancer, 1996, 77(8 Suppl):1668-1675. pmid: 8608560
[8]	Kusamura S, Baratti D, Zaffaroni N, et al. Pathophysiology and biology of peritoneal carcinomatosis[J]. World J Gastrointest Oncol, 2010, 2(1):12-18.
[9]	Huang J, Shen M, Yan M, et al. Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1[J]. Acta Biochim Biophys Sin(Shanghai), 2019, 51(9):900-907.
[10]	Pan L, Liang W, Fu M, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression[J]. J Cancer Res Clin Oncol, 2017, 143(6):991-1004.
[11]	Qu JL, Qu XJ, Zhao MF, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation[J]. Dig Liver Dis, 2009, 41(12):875-880.
[12]	Mukai S, Oue N, Oshima T, et al. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer[J]. J Pathol, 2017, 243(1):100-110.
[13]	Kitayama J, Yamaguchi H, Ishigami H, et al. Intraperitoneal mesenchymal cells promote the development of peritoneal metastasis partly by supporting long migration of disseminated tumor cells[J]. Plos One, 2016, 11(5):e0154542.
[14]	Miyake S, Kitajima Y, Nakamura J, et al. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer[J]. Int J Oncol, 2013, 43(5):1431-1440.
[15]	Panigrahi GK, Praharaj PP, Peak TC, et al. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells[J]. Sci Rep, 2018, 8(1):3853. doi: 10.1038/s41598-018-22068-4 pmid: 29497081
[16]	Zhihua Y, Yulin T, Yibo W, et al. Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer[J]. Cancer Sci, 2019, 110(8):2368-2377.
[17]	Chen J, Xu R, Xia J, et al. Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function[J]. Pathol Res Pract, 2019, 215(6):152379.
[18]	Xu Y, Jin X, Huang Y, et al. Inhibition of peritoneal metastasis of human gastric cancer cells by dextran sulphate through the reduction in HIF-1 α and ITG β 1 expression[J]. Oncol Rep, 2016, 35(5):2624-2634.
[19]	Wei M, Yang T, Chen X, et al. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells[J]. Oncotarget, 2017, 8(26):42262-42271.
[20]	Najgebauer H, Jarnuczak AF, Varro A, et al. Integrative omic profiling reveals unique hypoxia induced signatures in gastric cancer associated myofibroblasts[J]. Cancers (Basel), 2019, 11(2):263.
[21]	Tanaka M, Kuriyama S, Itoh G, et al. Mesothelial cells create a novel tissue niche that facilitates gastric cancer invasion[J]. Cancer Res, 2017, 77(3):684-695.
[22]	Sluiter N, de Cuba E, Kwakman R, et al. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options[J]. Clin Exp Metastasis, 2016, 33(5):401-416.
[23]	Du J, Liang Y, Li J, et al. Gastric cancer cell-derived exosomal microRNA-23a promotes angiogenesis by targeting PTEN[J]. Front Oncol, 2020, 10:326.
[24]	Zhang S, Zhang R, Xu R, et al. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3)[J]. Gene, 2020, 733:144383.
[25]	Li Y, Wu ZZ, Yuan J, et al. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis[J]. Cancer Let, 2017, 395:31-44.
[26]	Zhou Z, Zhang H, Deng T, et al. Exosomes carrying microRNA-155 target forkhead box O3 of endothelial cells and promote angiogenesis in gastric cancer[J]. Mol Ther Oncolytics, 2019, 15:223-233.
[27]	Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis[J]. Nat Commun, 2017, 8:15016.
[28]	Zhao K, Wang Z, Li X, et al. Exosome-mediated transfer of CLIC1 contributes to the vincristine-resistance in gastric cancer[J]. Mol Cell Biochem, 2019, 462(1-2):97-105. doi: 10.1007/s11010-019-03613-9 pmid: 31473882
[29]	Wang J, Lv B, Su Y, et al. Exosome-mediated transfer of lncRNA hottip promotes cisplatin resistance in gastric cancer cells by regulating HMGA1/MIR-218 axis[J]. Onco Targets Ther, 2019, 12:11325-11338.

Exosomes research in pathophysiology of peritoneal metastatic gastric cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 29

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang. Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 326-354.
[2]	SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei. Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 366-370.
[3]	SUN Qiang, YAO Jun, ZHANG Xin, DU Shanshan, WANG Weijun. Research progress of anti reflux digestive tract reconstruction for proximal gastrectomy [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 388-393.
[4]	YAN Su, ZHENG Minhua. Practice of single-port and reduced-port laparoscopic gastric cancer surgery in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 233-239.
[5]	HU Wenqing, YANG Yinhao, CUI Peng, WEI Wei. Current status of high-positioned digestive tract reconstruction after laparoscopic proximal stomach and lower esophagus resection through the abdominal-left diaphragmatic approach for adenocarcinoma of esophagogastric junction [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 226-232.
[6]	FAN Qingquan, SONG Xiaoling, GU Jun. Exosome in gastric cancer: research and perspective [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 177-180.
[7]	DENG Shijie, YUAN Fei. Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 53-57.
[8]	ZHANG Huan, CHEN Yong. New progression of radiomics in diagnosis of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 42-48.
[9]	LIU Wentao, LIU Fukun. Summary and prospect of perioperative comprehensive treatment for gastric cancer in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41.
[10]	LI Guoli, GUO Feilong. Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 31-35.
[11]	ZHAO Fazhi, ZHAO Ping. Formation and improvement of surgery-based treatment system for gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30.
[12]	LU Yiming, XIONG Jianping, TIAN Yantao. Current status and prospect of conversion therapy for far-advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23.
[13]	LI Jianfang, YU Junxian, YAN Chao, ZHU Zhenggang, LIU Bingya. Hotspots in basic and translational research of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 7-16.
[14]	ZHU Zhenggang. Progress and prospect of surgical comprehensive treatment of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6.
[15]	LUO Xi, SHI Yongmei, CHEN Ke, JIANG Shuo, WU Yuwei. Analysis on evaluation of patients with gastric and colon cancer using modified patient-generated subjective global assessment [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 545-550.